- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Zika vaccines and therapeutics: landscape analysis and challenges ahead ; volume:16 ; number:1 ; day:6 ; month:6 ; year:2018 ; pages:1-15 ; date:12.2018
BMC medicine ; 16, Heft 1 (6.6.2018), 1-15, 12.2018
- Classification
-
Medizin, Gesundheit
- Creator
-
Wilder-Smith, Annelies
- Contributor
-
Vannice, Kirsten
Durbin, Anna
Hombach, Joachim
Thomas, Stephen J.
Thevarjan, Irani
Simmons, Cameron P.
SpringerLink (Online service)
- DOI
-
10.1186/s12916-018-1067-x
- URN
-
urn:nbn:de:101:1-2018081122304434883230
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wilder-Smith, Annelies
- Vannice, Kirsten
- Durbin, Anna
- Hombach, Joachim
- Thomas, Stephen J.
- Thevarjan, Irani
- Simmons, Cameron P.
- SpringerLink (Online service)
Other Objects (12)
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
Developing Zika vaccines: the lessons for disease X
Intellectual property issues : therapeutics, vaccines and molecular diagnostics
Scabies vaccines: where we stand and challenges ahead
Ricin and Shiga toxins : pathogenesis, immunity, vaccines and therapeutics
Current perspectives on vaccines and therapeutics for Lassa Fever
Continuing development of vaccines and monoclonal antibodies against Zika virus
Mapping global public perspectives on mRNA vaccines and therapeutics
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics
CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics
Therapeutics, diagnostics, new vaccines, interferon treatment, and plasma proteins : with 16 tables
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
Developing Zika vaccines: the lessons for disease X
Intellectual property issues : therapeutics, vaccines and molecular diagnostics
Scabies vaccines: where we stand and challenges ahead
Ricin and Shiga toxins : pathogenesis, immunity, vaccines and therapeutics
Current perspectives on vaccines and therapeutics for Lassa Fever
Continuing development of vaccines and monoclonal antibodies against Zika virus
Mapping global public perspectives on mRNA vaccines and therapeutics
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics
CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics
Therapeutics, diagnostics, new vaccines, interferon treatment, and plasma proteins : with 16 tables
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
Developing Zika vaccines: the lessons for disease X
Intellectual property issues : therapeutics, vaccines and molecular diagnostics
Scabies vaccines: where we stand and challenges ahead
Ricin and Shiga toxins : pathogenesis, immunity, vaccines and therapeutics
Current perspectives on vaccines and therapeutics for Lassa Fever
Continuing development of vaccines and monoclonal antibodies against Zika virus
Mapping global public perspectives on mRNA vaccines and therapeutics
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics
CRISPR–Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics